“I thought I might focus my remarks today on several interrelated topics that have been of particular interest and concern to me, both during my tenure at the FDA, and throughout my career before coming to Washington.”
“This involves the importance of developing better, more sophisticated, and more efficient ways to use and build data and technology solutions to strengthen patient care and enhance the development of new treatments and cures. It involves both the innovation that is part of the development process and the process itself – making sure we have the data and technology systems and tools we need to support our scientific work.”
“As some of you may know, I was a clinician, as well as a professor of medicine at Duke Medical School, where I ran an organization called the Center for Learning Healthcare. In our work there we were very focused on these questions and closely studied ways that we could better organize data to strengthen health care opportunities.”
“In addition, I spent some time outside of the “ivory tower” of academia and joined a tech start up. I realized we needed to get some unconventional partners involved in these processes…” Read the full speech here.
Source: Remarks by Dr. Amy Abernethy to the FDA/CMS Summit – December 3, 2019. FDA.
